您的购物车当前为空
别名 XR-11576 HCl(346689-77-8 Free base)
XR-11576 HCl 是一种新型口服活性拓扑异构酶I 和II 双重抑制剂,具有抗肿瘤活性。

XR-11576 HCl 是一种新型口服活性拓扑异构酶I 和II 双重抑制剂,具有抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,300 | In Stock | |
| 5 mg | ¥ 2,900 | In Stock | |
| 10 mg | ¥ 4,290 | In Stock | |
| 25 mg | ¥ 6,850 | In Stock | |
| 50 mg | ¥ 9,270 | In Stock | |
| 100 mg | ¥ 12,500 | In Stock | |
| 500 mg | ¥ 24,800 | In Stock |
XR-11576 HCl 相关产品
| 产品描述 | XR-11576 HCl is a novel orally active dual topoisomerase I and II inhibitor with antitumor activity. |
| 靶点活性 | MRP:0.0121 µM, COR-L23 cells:0.0101 µM |
| 体外活性 | XR-11576对多药耐药的人类非小细胞肺癌细胞株COR-L23 (COR-L23/R),该细胞株过表达多药耐药蛋白 (MRP),表现出抑制作用(IC50=0.0121 µM)。[1] |
| 别名 | XR-11576 HCl(346689-77-8 Free base) |
| 分子量 | 424.92 |
| 分子式 | C23H25ClN4O2 |
| Smiles | COC1=CC=CC2=C3C(N=C4C(C(C(N[C@H](C)CN(C)C)=O)=CC=C4)=N3)=CC=C12.Cl |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (105.9 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容